Avrobio Inc (DELISTED) (AVRO:DL)
16.80
-0.24
(-1.41%)
USD |
NASDAQ |
Jun 20, 16:00
Avrobio Total Assets (Quarterly): 92.35M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 92.35M |
December 31, 2023 | 101.09M |
September 30, 2023 | 110.52M |
June 30, 2023 | 133.84M |
March 31, 2023 | 83.00M |
December 31, 2022 | 103.95M |
September 30, 2022 | 129.50M |
June 30, 2022 | 146.24M |
March 31, 2022 | 175.34M |
December 31, 2021 | 203.84M |
September 30, 2021 | 216.45M |
June 30, 2021 | 238.10M |
March 31, 2021 | 245.91M |
Date | Value |
---|---|
December 31, 2020 | 271.23M |
September 30, 2020 | 233.26M |
June 30, 2020 | 255.57M |
March 31, 2020 | 269.73M |
December 31, 2019 | 200.51M |
September 30, 2019 | 217.20M |
June 30, 2019 | 101.99M |
March 31, 2019 | 117.37M |
December 31, 2018 | 133.48M |
September 30, 2018 | 143.27M |
June 30, 2018 | 158.73M |
March 31, 2018 | 60.22M |
December 31, 2017 | 7.022M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
83.00M
Minimum
Mar 2023
271.23M
Maximum
Dec 2020
180.40M
Average
200.51M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
Agenus Inc | 256.56M |
BioCryst Pharmaceuticals Inc | 467.89M |
AIM ImmunoTech Inc | 16.19M |
Protalix BioTherapeutics Inc | 89.82M |
Armata Pharmaceuticals Inc | 120.36M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 3.509M |
Shareholders Equity (Quarterly) | 88.84M |